The only thing America can really do to get healthcare costs under control is actually really obvious: put down the fork.
What about the herion addicts that the healthcare system created? I don't think less food is going to solve their problems.
Economic Analysis of Medicare for All
81–90 of 111 posts
Re: Economic Analysis of Medicare for All
#82Earlier quoted context omitted.
And a lot of this is administrative overhead. Coming from a country outside of the US, I was also shocked by the price of medecine, every medecine magically seems to be 5-10x more expensive in the US.
The prices help pay for the huge cost involved in developing drugs. How many drugs were developed in France in the past 10 years compared to how many were developed in the US? You know the answer.
Since Sanofi based in France is one of the top 3 pharma companies, along with Roche based in neighbouring Switzerland, I'm guessing the answer will be quite a lot.
Re: Economic Analysis of Medicare for All
#83Earlier quoted context omitted.
> I know cardiologists pulling down 500k+ and that is ridiculous. I can see highly skilled surgeons making that much, but pill pushers? I don't know about you but I'm not willing to be a student until I'm in my mid 30s, working crazy hours, likely accumulating a significant amount of debt along the way, without some kind of a substantial payout on the other side.
Which is a good reason to not make doctors spend so many years in school. The Europeans don't and their doctors are just fine.
Also a good reason for state-funded higher education.
Re: Economic Analysis of Medicare for All
#84Earlier quoted context omitted.
This is the problem with a for-profit healthcare system. Meaningful reform is almost impossible because there's jobs on the line and therefore voters to contend with. More importantly, they are also probably highly educated and well paid voters. Doctors, software engineers, sales, etc. How much white collar employment comes from healthcare inefficiencies? Probably a good percentage of the sector. These workers will n…
US has a host of not-for-profit providers, they’re not drastically cheaper.
Mostly due to the existing for profit system. Not for profits still have to reside within the existing construct of American healthcare and hardly provide any real advantages when they negotiate with for profit entities.
Re: Economic Analysis of Medicare for All
#85Earlier quoted context omitted.
America has high costs anywhere that government is involved. Healthcare, infrastructure, etc...The pure private sector is quite efficient here.
How about internet access or cell phones? Is that the government's fault too?
Yes, those are excellent examples. Telecoms are heavily, heavily regulated.
Re: Economic Analysis of Medicare for All
#86Earlier quoted context omitted.
The prices help pay for the huge cost involved in developing drugs. How many drugs were developed in France in the past 10 years compared to how many were developed in the US? You know the answer.
Since Sanofi based in France is one of the top 3 pharma companies, along with Roche based in neighbouring Switzerland, I'm guessing the answer will be quite a lot.
The answer is very little compared to the whole market. And Sanofi targets the US market to fund its drug development. If they were not active there they would be a super minor company.
Re: Economic Analysis of Medicare for All
#87Earlier quoted context omitted.
The prices help pay for the huge cost involved in developing drugs. How many drugs were developed in France in the past 10 years compared to how many were developed in the US? You know the answer.
That's crap, often 80% of the price of a drug is marketing and profit.
Thats only if you consider the drug itself without all the cost of running operations and research. The actual profit margin at the company level is far from 80 percent. I suggest you read annual reports to educate yourself.
Re: Economic Analysis of Medicare for All
#88Earlier quoted context omitted.
The prices help pay for the huge cost involved in developing drugs. How many drugs were developed in France in the past 10 years compared to how many were developed in the US? You know the answer.
No, this is a myth. We know this because the same drugs often times cost a fraction of the price in other countries. The real reason drug prices are astronomical in the US is because the US government is legally prohibited from negotiating drug prices. So the pharmaceutical companies can literally set any price they want. You don’t have this problem with certain government agencies that are exempt from this prohibiti…
Does not matter how much it costs in other countries. the reality is that pharma companies make their revenues in the US at the level of 70 or 80 percent. You can be sure the level of investment would be very different if prices in the US were much lower. In practice the US is subsidizing drug development for the rest of the world.
Re: Economic Analysis of Medicare for All
#89Earlier quoted context omitted.
Uhh, you’re aware hospitals don’t turn people away who are injured and often end up with a lot owed to them they just can’t recover right? Also if everyone has healthcare they’ll get treated earlier before a condition blows up and... they get stuck at the ER getting a bill they’ll never be able to repay. Our US healthcare system just sucks compared to other countries UNLESS you are well off. I wouldn’t short change a…
Look up 5-year cancer survival rates by country. That metric at least attempts to measure the performance of the healthcare system. The studies that say our healthcare system "sucks" are looking at overall health of each country's population, not the performance of their systems. To condemn the healthcare system based on the overall health of a nation that spends all day watching TV and shoving cheeseburgers in its f…
I’d say the system sucks when a valid reason to exclude someone form an organ transplant is “don’t have 10k in savings to cover rejection meds”.
Without Medicare for all it’s a pay to win system where the cost of life saving treatments are literally beyond what most people could ever reasonably make.
Re: Economic Analysis of Medicare for All
#90Earlier quoted context omitted.
The prices help pay for the huge cost involved in developing drugs. How many drugs were developed in France in the past 10 years compared to how many were developed in the US? You know the answer.
I know that's what's pushed, but how much of that is true? Federal grants pay for a lot of initial frubt work, and drug companies spend around twice as much on marketing as they do on R&D. And that's with all sorts of tax benefits behooving them to call as much as possible of their budget R&D.
Marketing is needed everywhere, pharma included. You dont spread awareness of a new drug just by filing an application to the FDA. And marketing expenses are high because potential returns are high and make or break a drug. Note that you dont have really new drugs every year so you need marketing anyway to convince prescribers why your version of the drug in the same class as your competitor is slightly better. In reality most drugs of the same class are pretty similar in efficacy and side effects, but thats a tangential topic.